[1] Horn J, Tanz LJ, Stuart JJ, et al.Early or late pregnancy loss and development of clinical cardiovascular disease risk factors: a prospective cohort study[J]. BJOG,2019,126(1):33-42.
[2] 陈小琳,慕婷,雷洁. 血肾损伤分子1与β2微球蛋白浓度在妊娠期高血压并发早期肾损伤的诊断价值[J].中国综合临床,2020,36(3):263-266.
[3] 常丽花,梁婉琪,李艳川,等.血清Cys C、KIM-1、β2-MG对妊娠期高血压疾病患者肾损伤的诊断价值[J].中国计划生育学杂志,2021,29(02):336-339,425.
[4] Ou M, Zhao H, Ji G, et al.Long noncoding RNA MALAT1 contributes to pregnancy-induced hypertension development by enhancing oxidative stress and inflammation through the regulation of the miR-150-5p/ET-1 axis[J]. FASEB J, 2020,34(5):6070-6085.
[5] 肖磊,刘怀昌,谈炯新.妊娠期高血压病患者血清内皮微颗粒、内皮素-1、单核细胞趋化蛋白-1及NO水平与病情严重程度相关[J].内科急危重症杂志,2024,30(4):343-345.
[6] 郭陆晋,李逸群,郑晖,等.MiR-146a、sLOX-1、HCY诊断妊娠期高血压疾病合并肾功能损害效果[J].中国计划生育学杂志,2021,29(9):1907-1910,1915.
[7] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4):227-238.
[8] 丁峰,张晓静,李海娇,等.sFlt-1、 ET-1、 MFG-E8水平对妊娠期高血压疾病肾功能损伤的预测价值[J].中国病案,2021,22(11):109-112.
[9] 应葛霏,章茜茜.不同程度妊娠期高血压疾病患者血清ET-1、NO、CysC水平及肾功能指标变化[J].中国计划生育学杂志,2022,30(9):2107-2110.
[10] Campbell N, LaMarca B, Cunningham MW Jr. The role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathophysiology of preeclampsia[J]. Curr Pharm Biotechnol,2018,19(10):781-785.
[11] 孙亚妮,雷静,吕海荣.妊娠期高血压疾病患者血清ET、NO水平及动脉弹性分析[J].海南医学,2021,32(5):607-610.
[12] Ma L, Li L, Han P, et al.Effect of the drug combination of magnesium sulfate and phentolamine on homocysteine and C-reactive protein in the serum of patients with pregnancy-induced hypertension syndrome[J]. Exp Ther Med,2019,17(5):3682-3688. |
